Search for: "Holman" Results 661 - 680 of 747
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Feb 2010, 3:07 am by Bob Kraft
 In his column in the Wall Street Journal (2/26), Holman Jenkins suggests that this week's congressional hearings into Toyota's safety issue were for the benefit of trial lawyers, and dismisses the notion that electronic faults could be to blame for incidents of unintended acceleration. [read post]
27 Jan 2010, 3:00 am
Kappos (Patent Docs) US: Calculating PTA: PTO to offer ‘guidance for expediting requests’ (Patently-O) US: Senate votes against Bill allowing Americans to import prescription drugs (Pharmacapsules@Gowlings) US: Governors write President in support of 12-year data exclusivity period (Patent Docs) US: Obama moving to renegotiate biologics exclusivity period (Pharmacapsules@Gowlings) US: Law Professors Adelman and Holman contend that data exclusivity is secondary issue in follow-on… [read post]
31 Aug 2006, 6:14 am
This brings us to the fresh breath of sanity visited upon this sorry non-scandal by Holman Jenkins of the WSJ, who writes today about the accounting fiction at the heart of all this. [read post]
5 Aug 2009, 5:35 am
. - Patent Docs) US: America’s Affordable Health Choices Act : House Energy & Commerce Committee OKs 12-year data exclusivity for biotech drugs (Patent Baristas) (Patent Docs) (FDA Law Blog) (PatentlyBIOtech) (GenericsWeb) US: Patents and data exclusivity: It ain’t necessarily so (Patent Docs) US: Teva fights for biotech generics (GenericsWeb) US bill considers access to Canadian pharmaceuticals (Pharmacapsules@Gowlings) US: Bilski and biotechnology – an update… [read post]
7 Apr 2010, 4:30 am
– Myriad stock prices: Association of Molecular Pathology v USPTO (Innovationpartners) US: Federal judge in Myriad patent case says invalidation of gene patents does not violate TRIPS: Association of Molecular Pathology v USPTO (KEI) US: ACLU gene patent decision from an investor’s perspective: A black eye for the US patent system: Association of Molecular Pathology v USPTO (Holman's Biotech IP Blog) US: Association of Molecular Pathology v USPTO: What the parties are… [read post]
22 Dec 2010, 4:30 am by Jason Rantanen
Additional CommentaryIn addition to an extensive discussion about the decision in response to Dennis's post on Sunday, other sites commenting on the decision include: Patent Docs patents4life IP Watchdog Chris Holman's IP Blog Hal Weger of Foley has suggested that another grant of certiorari may be down the road, given the opinion's refusal to discuss a three-Justice dissent from the dismissal of certiorari in Lab. [read post]
28 Mar 2010, 7:46 pm by Dennis Crouch
  Also telling is the citation by Gajarsa in his concurrence of work by Dennis Crouch and Chris Holman showing that few cases have invalidated claims based on written description. [read post]
6 Oct 2023, 12:22 am by David Pocklington
When discussing heating on a DAC visit we were told that they would not be in favour of hanging heaters as this would visually impact the open feel of the church and the flow of one’s eyes to the beautiful Holman Hunt stained glass East Window”. [read post]
28 Jan 2012, 9:13 am by Buce
  And here's Holman Jenkins in The Wall Street Journal saying everything's all right here folks, move along. [read post]
17 Nov 2010, 1:48 am by Kelly
(Patently-O) US: Amicus brief filed by Alnylam Pharmaceuticals argues that Funk Bros. is about obviousness, not patent eligibility: AMP v USPTO (Holman’s Biotech IP Blog) US: Amicus briefs in AMP v USPTO: Genetic Alliance (Patent Docs) US: Patent expirations will stabilise the pharmaceutical industry (BiotechBlog) US: Generic industry headed for a ‘180-day exclusivity cliff’ (FDA Law Blog) US: PTO clarifies PTE availability in post-PhotoCure and post-Ortho-McNeil world;… [read post]
22 Jul 2020, 8:44 am by Dani Selby
Elder Carl Payne and Pervis Payne (16); Photo Courtesy of Rolanda Payne Holman. 8. [read post]
17 Jul 2007, 2:01 pm
"The producer of this reality show has not thought this one through," said Craig Holman, a campaign finance lobbyist for Public Citizen. [read post]
7 May 2021, 12:50 am by Tessa Shepperson
Dr Nancy Holman, Associate Professor of Urban Planning and co-author of the report, said: Unfortunately, these solutions are partial. [read post]
Di Holman is Chief People Officer at Virgin Pulse and guides all aspects of Human Resources, including business partnering; talent management; total rewards; internal communications; and diversity, equity, and inclusion across all global locati The post Three Strategies for Developing a Positive & Inclusive Hybrid Employee Experience appeared first on HR Daily Advisor. [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to… [read post]
16 Mar 2011, 3:50 am by Marie Louise
Abbott: Federal Circuit struggles to articulate a coherent standard for compliance with the Lilly written description requirement (Holman’s Biotech IP Blog) Lexapro (Escitalopram) – US: CAFC affirms obviousness of Infosint’s patent claims (IPBiz) Lotronex (Alosetron) – US: Prometheus files patent infringement suit against Roxane in response to Para IV challenge (Patent Docs) Pravastatine – Belgium/France: Post-expiry saisie-contrefaçon: Belgium and… [read post]